Literature DB >> 7829005

Release of vasodilator, but not vasoconstrictor, neuropeptides and of enteroglucagon by intestinal ischaemia/reperfusion in the rat.

L Meleagros1, M A Ghatei, S R Bloom.   

Abstract

Reperfusion of ischaemic intestine is characterised by an initial hyperaemia with ensuing mucosal repair. This study investigated possible roles for gut vasoactive neuropeptides and trophic peptides in these phenomena. Groups of rats were monitored during superior mesenteric artery occlusion for five or 20 minutes, with or without subsequent reperfusion for five minutes. Peptide concentrations (fmol/ml) in arterial blood, were measured using specific radioimmunoassays. Intestinal ischaemia alone did not cause haemodynamic disturbance or peptide release. Reperfusion, after five minutes of ischaemia, resulted in arterial hypotension and a rise in plasma vasoactive intestinal polypeptide (mean (SEM)) (37 (3), control 11 (4), p < 0.001). After 20 minutes of ischaemia, reperfusion resulted in greater hypotension (p < 0.05) and release of both vasoactive intestinal polypeptide (31 (3), p < 0.05 v control) and the more potent vasodilator beta-calcitonin gene related peptide (49 (3), control 23 (1), p < 0.001). By contrast, the vasodilators alpha-calcitonin gene related peptide and substance P and the vasoconstrictors neuropeptide Y, peptide YY, and somatostatin were not released. Bombesin, a stimulatory neuropeptide, was released after 20 minutes of ischaemia/reperfusion (13 (2), control 7 (3), p < 0.05). Plasma enteroglucagon rose from control (51 (4)) to 110 (16) (p < 0.001) and to 158 (27) (p < 0.005) after five and 20 minutes of ischaemia/reperfusion. The potent enteric vasodilators vasoactive intestinal polypeptide and beta-calcitonin gene related peptide, unopposed by vasoconstrictors, may promote post-ischaemic intestinal hyperaemia. The rise in plasma enteroglucagon may point to diffuse mucosal injury and is consistent with the putative trophic role of this peptide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7829005      PMCID: PMC1375256          DOI: 10.1136/gut.35.12.1701

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  42 in total

1.  Sequence of morphological alterations in a small intestinal ischaemia/reperfusion model of the anesthetized rat. A light microscopy study.

Authors:  G Illyés; J Hamar
Journal:  Int J Exp Pathol       Date:  1992-04       Impact factor: 1.925

2.  The neuronal origin of bombesin-like immunoreactivity in the rat gastrointestinal tract.

Authors:  G J Dockray; C Vaillant; J H Walsh
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

Review 3.  Peptidergic nerves.

Authors:  A E Bishop; G L Ferri; L Probert; S R Bloom; J M Polak
Journal:  Scand J Gastroenterol Suppl       Date:  1982

Review 4.  Intestinal blood flow.

Authors:  D N Granger; P D Richardson; P R Kvietys; N A Mortillaro
Journal:  Gastroenterology       Date:  1980-04       Impact factor: 22.682

5.  Metabolic control of intestinal oxygenation and blood flow.

Authors:  A P Shepherd
Journal:  Fed Proc       Date:  1982-04

6.  Localization of peptide YY (PYY) in gastrointestinal endocrine cells and effects on intestinal blood flow and motility.

Authors:  J M Lundberg; K Tatemoto; L Terenius; P M Hellström; V Mutt; T Hökfelt; B Hamberger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  Vasoactive intestinal polypeptide is more potent than prostaglandin E2 as a vasodilator and oedema potentiator in rabbit skin.

Authors:  T J Williams
Journal:  Br J Pharmacol       Date:  1982-11       Impact factor: 8.739

8.  Bombesin: action on gut hormones and calcium in man.

Authors:  M A Ghatei; R T Jung; J C Stevenson; C J Hillyard; T E Adrian; Y C Lee; N D Christofides; D L Sarson; K Mashiter; I MacIntyre; S R Bloom
Journal:  J Clin Endocrinol Metab       Date:  1982-05       Impact factor: 5.958

9.  The release of vasoactive intestinal peptide during altered mid-gut blood flow.

Authors:  P G Bateson; K D Buchanan; D M Stewart; T G Parks
Journal:  Br J Surg       Date:  1980-02       Impact factor: 6.939

10.  Plasma vasoactive intestinal polypeptide (VIP) levels and intestinal ischaemia.

Authors:  I M Modlin; S R Bloom; S Mitchell
Journal:  Experientia       Date:  1978-04-15
View more
  4 in total

Review 1.  Gut hormones, and short bowel syndrome: the enigmatic role of glucagon-like peptide-2 in the regulation of intestinal adaptation.

Authors:  G-R Martin; P-L Beck; D-L Sigalet
Journal:  World J Gastroenterol       Date:  2006-07-14       Impact factor: 5.742

2.  Oesophageal epithelial innervation in health and reflux oesophagitis.

Authors:  M Newton; M A Kamm; P O Soediono; P Milner; W R Burnham; G Burnstock
Journal:  Gut       Date:  1999-03       Impact factor: 23.059

3.  Homeostasis in the small intestinal mucosa balanced between cell proliferation and apoptosis is regulated partly by the central nervous system.

Authors:  Kazuma Fujimoto; Ryuichi Iwakiri; Bin Wu; Takehiro Fujise; Seiji Tsunada; Akifumi Ootani
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

4.  Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction.

Authors:  Chun-Hua Hang; Ji-Xin Shi; Jie-Shou Li; Wei Wu; Wei-Qin Li; Hong-Xia Yin
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.